sglt2 inhibitors and glp 1 receptor agonists GLP-1 in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Prescribe SGLT2 inhibitors, GLP-1 receptor

It is a designation used primarily by the FDA (Food and Drug Administration) for products, often in vitro diagnostic (IVD) components like reagents or instruments, that are in the laboratory research phase of development and are not intended for clinical diagnostic use

Ciacci C, Peluso G, Iannoni E, et al

Targeting different sites involved in Caspase interactions with XIAP using small-molecule chemical inhibitors induces synergistic apoptosis of leukemia cells

By repressing cardiac peroxisome proliferator-activated receptor-, miR-199a facilitates a metabolic shift from a predominant reliance on fatty acid utilization toward an increased reliance on glucose metabolism, which leads to lethal heart failure (36)

Directions Recommended dose: 1 capsule per day